Welcome to Respiratory


in
The respiratory diseases market in consists of asthma, COPD (Chronic obstructive pulmonary disease), allergic rhinitis and cystic fibrosis. Despite the respiratory diseases therapeutics market is in its growth to maturity phase, the market is set to witness sustained growth in the coming years. The increasing patient base, advanced diagnostic techniques and efficient drug therapies are bound to favour the growth of the respiratory diseases market. The respiratory drugs used for asthma and COPD treatment account for 50.0 per cent of the sales. The rest of the respiratory drugs sales cater to allergic rhinitis, cough, cold, cystic fibrosis and pneumonia.